Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 286

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial

Open access
Gao, Peng, Wang, Tao, Wang, Daming, Liebeskind, David S., Shi, Huaizhang, Li, Tianxiao, Zhao, Zhenwei, Cai, Yiling, Wu, Wei, He, Weiwen, Yu, Jia, Zheng, Bingjie, Wang, Haibo, Wu, Yangfeng, Dmytriw, Adam A., Krings, Timo, Derdeyn, Colin P., Jiao, Liqun, CASSISS Trial Investigators, Jiao, Liqun, Wang, Daming, Krings, Timo, Libeskind, David S, Shi, Huaizhang, Li, Tianxiao, Zhao, Zhenwei, Wu, Wei, Cai, Yiling, He, Weiwen, Huang, Shengping, Yin, Long, Gu, Yuxiang, Zhang, Hongqi, Ling, Feng, Caplan, Louis R., Zaidat, Osama, YU, Simon Chun Ho, Sun, Qinjian, Lu, Jie, Bao, Yuhai, Yang, Kun, Song, Haiqing, Chen, Wenhuo, Chi, Haitao, Wang, Shouchun, Zhang, Jin, Chen, Fei, Li, Shenmao, Zhang, Xiaobo, Sui, Hong, Hu, Weiwu, Li, Long, Feng, Yao, Gao, Peng, Wang, Tao, Wang, Haibo, Zhu, Yidan, Zheng, Bingjie, Qi, Peng, Chen, Kunpeng, He, Yingkun, Yu, Jia, Gong, Weigang, Du, Juan, Cui, Yongqiang, Chen, Yachong · 2022 · JAMA

Abstract

Importance: Prior randomized trials have generally shown harm or no benefit of stenting added to medical therapy for patients with symptomatic severe intracranial atherosclerotic stenosis, but it remains uncertain as to whether refined patient selection and more experienced surgeons might result in improved outcomes. Objective: To compare stenting plus medical therapy vs medical therapy alone in patients with symptomatic severe intracranial atherosclerotic stenosis. Design, Setting, and Participants: Multicenter, open-label, randomized, outcome assessor-blinded trial conducted at 8 centers in China. A total of 380 patients with transient ischemic attack or nondisabling, nonperforator (defined as nonbrainstem or non-basal ganglia end artery) territory ischemic stroke attributed to severe intracranial stenosis (70%-99%) and beyond a duration of 3 weeks from the latest ischemic symptom onset were recruited between March 5, 2014, and November 10, 2016, and followed up for 3 years (final follow-up: November 10, 2019). Interventions: Medical therapy plus stenting (n = 176) or medical therapy alone (n = 182). Medical therapy included dual-antiplatelet therapy for 90 days (single antiplatelet therapy thereafter) and stroke risk factor control. Main Outcomes and Measures: The primary outcome was a composite of stroke or death within 30 days or stroke in the qualifying artery territory beyond 30 days through 1 year. There were 5 secondary outcomes, including stroke in the qualifying artery territory at 2 years and 3 years as well as mortality at 3 years. Results: Among 380 patients who were randomized, 358 were confirmed eligible (mean age, 56.3 years; 263 male [73.5%]) and 343 (95.8%) completed the trial. For the stenting plus medical therapy group vs medical therapy alone, no significant difference was found for the primary outcome of risk of stroke or death (8.0% [14/176] vs 7.2% [13/181]; difference, 0.4% [95% CI, -5.0% to 5.9%]; hazard ratio, 1.10 [95% CI, 0.52-2.35]; P = .82). Of the 5 prespecified secondary end points, none showed a significant difference including stroke in the qualifying artery territory at 2 years (9.9% [17/171] vs 9.0% [16/178]; difference, 0.7% [95% CI, -5.4% to 6.7%]; hazard ratio, 1.10 [95% CI, 0.56-2.16]; P = .80) and 3 years (11.3% [19/168] vs 11.2% [19/170]; difference, -0.2% [95% CI, -7.0% to 6.5%]; hazard ratio, 1.00 [95% CI, 0.53-1.90]; P > .99). Mortality at 3 years was 4.4% (7/160) in the stenting plus medical therapy group vs 1.3% (2/159) in the medical therapy alone group (difference, 3.2% [95% CI, -0.5% to 6.9%]; hazard ratio, 3.75 [95% CI, 0.77-18.13]; P = .08). Conclusions and Relevance: Among patients with transient ischemic attack or ischemic stroke due to symptomatic severe intracranial atherosclerotic stenosis, the addition of percutaneous transluminal angioplasty and stenting to medical therapy, compared with medical therapy alone, resulted in no significant difference in the risk of stroke or death within 30 days or stroke in the qualifying artery territory beyond 30 days through 1 year. The findings do not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe intracranial atherosclerotic stenosis. Trial Registration: ClinicalTrials.gov Identifier: NCT01763320.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2022.12000

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 286

Metadata

Authors
Gao, P., Wang, T., Wang, D., Liebeskind, D. S., Shi, H., Li, T., Zhao, Z., Cai, Y., Wu, W., He, W., Yu, J., Zheng, B., Wang, H., Wu, Y., Dmytriw, A. A., Krings, T., Derdeyn, C. P., Jiao, L., CASSISS Trial Investigators, Jiao, L., Wang, D., Krings, T., Libeskind, D. S., Shi, H., Li, T., Zhao, Z., Wu, W., Cai, Y., He, W., Huang, S., Yin, L., Gu, Y., Zhang, H., Ling, F., Caplan, L. R., Zaidat, O., YU, S. C. H., Sun, Q., Lu, J., Bao, Y., Yang, K., Song, H., Chen, W., Chi, H., Wang, S., Zhang, J., Chen, F., Li, S., Zhang, X., Sui, H., Hu, W., Li, L., Feng, Y., Gao, P., Wang, T., Wang, H., Zhu, Y., Zheng, B., Qi, P., Chen, K., He, Y., Yu, J., Gong, W., Du, J., Cui, Y., & Chen, Y.
Venue
JAMA
Published
2022-08-09
Volume
328
Issue
6
Pages
534
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4290793582
Cited by
286
References
29
FWCI
31.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2022.12000
The paper
Gao, P., Wang, T., Wang, D., Liebeskind, D. S., Shi, H., Li, T., Zhao, Z., Cai, Y., Wu, W., He, W., Yu, J., Zheng, B., Wang, H., Wu, Y., Dmytriw, A. A., Krings, T., Derdeyn, C. P., Jiao, L., CASSISS Trial Investigators, . . . Chen, Y. (2022). Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2022.12000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.